We retrospectively analyzed 252 patients with end-stage liver disease who had undergone LDLT from January 2009 to September 2015. Of these, 25 had a GRWR of <2.0% (Group A), 204 had a GRWR of ≥2.0% or <4.0% (Group B), and 23 had a GRWR ≥4.0% (Group C). The three GRWR groups demonstrated similar characteristics, except for recipient age and recipient BMI. The overall 1-, 2-, and 3-year graft survival rates were 95.1%, 93.5%, and 93.5%, respectively. However, among the three groups, graft survival rates at 1 year, 2 years, and 3 years were significantly different (P = .0009). Hepatic artery stenosis/thrombosis was more frequently observed in Group C than in Groups A and B (P = .001). Wound infection was also more frequently observed in Group C than in Group A and B (P = .002). However, intestinal fistula/bile leakage/biliary-enteric anastomotic fistula was more frequently observed in Group A than in Groups B and C (P = .001). In addition, reoperation more frequently occurred in Group A and C than in Group B (P = .001). Recipients with a GRWR between 2.0% and 4.0% had significantly better graft survival rates.
| INTRODUCTION
The first living-donor liver transplantation (LDLT) procedure was performed in 1988 as a life-saving procedure for a 4-year-old girl with terminal advanced liver failure due to biliary atresia. 1 After the first successful LDLT in 1989, this revolutionary procedure was gradually accepted. 2 Due to the scarcity of organs available for deceased-donor transplantation, LDLT has seen great progress in terms of patient experience and techniques, as well as pre-, peri-, and post-transplant management. [3] [4] [5] Ueda et al reported that patient and graft survival rates after pediatric LDLT in a large cohort of children at their center were similar to the survival rates for cadaveric liver transplantation. Patient survival at 1, 5, and 10 years was 84.6%, 82.4%, and 77.2%, respectively, and the corresponding findings for graft survival were 84.1%, 80.9%, and 74.5%. 6 After nearly 30 years of development, LDLT has become an effective therapy for children with end-stage liver disease. [7] [8] [9] The majority of the recipients received LDLT for biliary atresia (BA), because the size of the abdominal cavity in cirrhotic baby seems to be different from metabolic and ALF children. 10 Various factors, including the graftto-recipient weight ratio (GRWR), should be initially assessed to determine their influence on graft survival and outcomes. Kasahara 
| Medication and immunosuppression protocol
The immunosuppressant basiliximab (10 mg intravenous infusion)
was administered intraoperatively and on postoperative day 4.
Methylprednisolone was administered at a dose of 10 mg/kg (intravenous infusion) after reperfusion of the grafts, followed by 1-2 mg/kg 4 times daily for the first day, with tapering to 1 mg/kg once daily on day 6. From day 7, methylprednisolone was taken orally and discontinued at the end of the first 3-12 months after LDLT. Tacrolimus (0.1 mg/ kg) was administered via a nasogastric tube 36 hours after transplantation, with dose adjustment to maintain trough blood levels at 8-10 ng/mL during the first month and then at 5-8 ng/mL thereafter.
Some patients were also treated with mycophenolate mofetil (250 mg twice daily, orally), which was withdrawn at 3-6 months postoperative.
Hepatic artery thrombosis was controlled by intravenous infusion of heparin, while the patients were in the intensive care unit; they were then switched to oral warfarin, with dose adjustment to maintain the prothrombin time at approximately twofold longer than that of the controls.
| Follow-up
The surviving children were followed up in the clinic weekly during the first 3 months after LDLT, biweekly from 4 to 6 months postoperative, monthly from the seventh to the 12th month, and every 3 months thereafter. The following tests were performed at each follow-up visit: height, body weight, serum liver tests, renal function tests, serological concentration of immunosuppressive agents, serological cytomegalovirus (CMV) tests, and Epstein-Barr virus (EBV)
tests. Abdominal sonography was performed every 3 months during the first 2 years and annually thereafter. All recipients were followed until death, graft loss, or December 2015.
| Statistical analysis
Statistical analyses were performed using commercially available software (SPSS version 23.0; SPSS Inc, Chicago, IL, USA). Categorical data are presented as numbers with percentages, and continuous data are presented as the means ± SD or medians with a range, depending on the normality of the distribution. Clinical variables were analyzed using the chi-square test or Fisher's exact test for categorical data, and the Kruskal-Wallis H test was used for continuous data. The cumulative survival curves for patients and grafts were plotted using the Kaplan-Meier method, and curves were compared using the log-rank test. P-values <.05 were considered statistically significant.
| RESULTS

| Recipients and donors
Between Table 1 . The original liver diseases of the patients are listed in Table 2 . The recipient gender and PELD score and the donor age, gender, and BMI were not different among the groups. However, the recipient age and BMI were significantly higher in Group A than in Groups B and C (P < .0001). Twenty-five (9.9%) patients had a GRWR <2.0% (Group A), 204 (81.0%) had a GRWR ≥2.0%
or <4.0% (Group B), and 23 (9.1%) had a GRWR ≥4.0% (Group C). The median GRWRs among the three groups were 1.60% for Group A, 2.75% for Group B, and 4.33% for Group C. The minimum GRWR was 0.75%, and the maximum GRWR was 5.24%. The GRWR was significantly different among the groups (P < .0001).
| Operative characteristics
In 249 cases, the left lateral segment (II and III) was harvested. In two donors, the left lobe (II-IV) was removed along with the middle hepatic vein, and in the remaining two donors, the right lobe was harvested.
In terms of operative factors, no significant differences were observed regarding cold ischemic time, warm ischemic time, operation time, and estimated blood loss (Table 3 ).
| Postoperative complications and laboratory changes
The postoperative complications after LDLT in the three groups are listed in Table 4 However, a difference in serum ALB was not observed among the three groups. Furthermore, the above four indicators reached normal levels within 2 weeks after LDLT.
T A B L E 1 Clinical characteristics of recipients and donors according to GRWR T A B L E 2 Original liver diseases of the patients
| DISCUSSION
The GRWR is a useful index to evaluate the graft and patient survival rate, as well as outcomes of LT patients. When the GRWR was less than 0.8%, patients suffered from encephalopathy, coagulopathy, and cholestasis and had poor graft survival. 13, 14 Moon et al 15 showed that donor age was the only significant risk factor for poor graft survival in LDLT, and a graft with a GRWR <0.8% can be used safely when a recipient is receiving the graft from a donor younger than 44 years. In a study by Seung DL et al, 16 317 patients underwent LDLT and were categorized into three groups by GRWR, the authors concluded that a GRWR lower than 0.7% is safe and does not require portal pressure modulation in adult-to-adult LDLT using the right lobe under favorable conditions, including a low model for end-stage liver disease score. In patients with a GRWR >2.5%, the rate of respiratory failure was higher than the rates of other postoperative complications. 17 The aforementioned research mainly examined the effect of the GRWR in adult liver transplantation. We found that when the GRWR was less than 1%, the patient survival rate was lower, likely due to enhanced parenchymal cell injury and reduced metabolic and synthetic capacity. However, the negative impact of large-for-size grafts was less pronounced in this study. Another limitation of the study is that adult and pediatric patients were not separately analyzed. 13 Obviously, anatomical and physiological characteristics of the liver differ between children and adults. We acknowledge that liver volume per body weight decreases with the growth of children. 18 The data corroborate a large variation in the size of liver segments, even in healthy living donors. Therefore, precise measurement of a donor's liver by CT volumetry is essential before operating. Due to limited data, a reasonable range of the GRWR for pediatric LDLT remains unknown. Our data clearly demonstrated that recipients with a GRWR ranging from 2.0% to 4.0% showed positive results. Whether serum ALT and AST levels were higher in recipients with a GRWR greater than 4.0% during the first week after LDLT remains to be determined. The fact that the serum TB level was higher in recipients with a GRWR <2.0% during the first 3 days after LDLT may be related to the reduced metabolic and synthetic capacity.
In a study of 47 pediatric cases, it was demonstrated that graft size matching is not necessarily a serious problem for living-related GRWR, graft-to-recipient weight ratio; PTLD, post-transplant lymphoproliferative disorders.
T A B L E 4 Postoperative complications of recipients according to GRWR (n, %)
partial liver transplants with a GRWR ranging from 0.61% to 6.0% with respect to blood supply, tissue oxygenation, and metabolic capacity, as long as the liver graft is anatomically fit to the recipient.
Furthermore, the authors also reported that living-related partial liver transplantation for small infants with relatively large grafts can be performed successfully when blood flow to the graft is ensured. Shunt ligation should be performed as needed by duplex Doppler sonography. In addition, the authors speculated that living-related partial liver transplantation for adolescents or adults with relatively small grafts can be performed successfully when early regeneration is ensured.
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A recent study reported that when infant recipients weighed ≤8 kg and had a GRWR within the range of 1.9% and 5.8%, no noticeable adverse events occurred. However, it was speculated that a reduction in the graft mass should still be considered an applicable strategy for select cases.
12
A report by Bonatti et al highlighted two major complications that resulted from transplanting a graft that is too large. The first is inadequate perfusion of the liver, resulting in graft dysfunction, and the second is abdominal wall closure, which can cause graft compression or diaphragmatic splinting and can result in respiratory complications.
Temporary abdominal closure using a silastic patch is advisable in such cases. 20 The study showed that reduction in the left lateral segment (LLS) was considered when the estimated GRWR of the LLS of the donor was >4.0%. In one case, when the GRWR was >4.0% and the ratio of the thickness (the ratio of the maximum thickness of the LLS to the anteroposterior diameter in the recipient's abdominal cavity) was <1.0, non-anatomically reducing LLS was considered. In another case, when the GRWR was >4.0% and the ratio of thickness was ≥1.0, a segment 2 graft was considered. 21 In contrast, several studies maintain that the GRWR should be at least 1% in pediatric LDLT. However, MODS, multiple organ dysfunction syndrome.
